|
 |
LunestaThis page contains recent news articles, when available, and an overview of Lunesta but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....and Tylenol® PM) or prescription sleep medication (including old standbys such as Valium and Halcion, newer generation drugs such as Lunesta® and Ambien ... Book of Odds Deutsch Loses Chief Strategy Officer to Kirshenbaum - 06 Jan 2010 ...while Lowe was forced to say goodbye to its Zicam account and the sleep-aid Lunesta due to account conflicts that arose from the merger. AdAge.com Sepracor gets extension of Lunesta patent protection - Dec 18, 2009 Sepracor reported today that the US Patent and Trademark Office has extended patent protection on Lunesta by 760 days to Feb. 14, 2014. ... Worcester Telegram Sepracor gets patent term extension for Lunesta - Dec 22, 2009 6444673, which is a composition of matter patent that covers the human drug product Lunesta (eszopiclone), received a patent term extension under 35 USC ... pharmabiz.com Warning: Driving while sleeping isn't advisable - Dec 18, 2009 It's for a drug called Lunesta and, apparently if you take it, you'll find yourself sleeping peacefully in no time at all. And, according to the ad, ... Canoe.ca (blog) Unveiled: Tiger Woods's Thirteenth Mistress! - Dec 11, 2009 ..."Before Chris knew it, the both of them were taking Lunesta, listening to Jimmy Buffett, and rolling around in soiled diapers at the Mercer Hotel. ... New York Magazine Happy New Year? - Dec 30, 2009 That's because I've actually been suffering a slew of sleepless nights (including Restless Leg Syndrome for which I take Lunesta) knowing that "cable TV and ... Huffington Post (blog) A new high: Abuse of prescription drugs now surpasses illegal narcotics - Dec 26, 2009 ...and tranquilizers like Xanax, Valium and lithium are being combined with sleep aids such as Ambien and Lunesta in a deadly sedative cocktail, ... Reading Eagle 'Go Ask Your Doctor if the Purple Pill is Right for You' - Dec 10, 2009 Dorgan went on to do dramatic readings for sleep aids Ambien CR and Lunesta, and prostate drugs Enablex, and Flomax. The Flomax ad was really where he hit ... MedPage Today (blog) Director/VFX Artist Sam O'Hare Joins Aero Film - Dec 15, 2009 The New York-based O'Hare had at press time wrapped a campaign for Lunesta. He joins a directorial roster at the Santa Monica-based Aero that includes Klaus ... SHOOT Online ASK DR H: Alternative sweeteners do not contain sugar alcohol - Dec 16, 2009 Q: Don't you think that all those commercials that air constantly about Viagra, Cialis, Lunesta, Boniva and the like are getting to be too much? ... Atlanta Journal Constitution (blog) Santa reveals route for tomorrow night - Dec 24, 2009 AN UNNAMED SOUTHEAST TEXAS COACH—The Lunesta Award for taking the product to eliminate insomnia and now he has nightmares about a lighted green butterfly ... TheRecordLive.com Aught nine just ducky for Top of Utahns - Dec 26, 2009 As news of the possible programming leaks out, stock prices for Ambien, Lunesta and other sleep-aid products tumble sharply. 9 -- A gay couple is detained ... StandardNet Blackstrap molasses treats hemorrhoids - Dec 29, 2009 We are sending you our “Guide to Getting a Good Night's Sleepâ€? with more details on prescription sleep aids like Sonata and Lunesta as well as further ... The Spokesman Review A Healthcare Carol - Dec 21, 2009 ...“Away ye spirit,â€? I intoned, “for I need my sleep and indeed see you for what you really are – a detail rep for Lunesta.â€? “Nay,â€? replied the apparition. ... Reuters (press release) (blog) Zolpidem: Drug Whys - Dec 16, 2009 An agent similar to zolpidem entered the pharmaceutical market in 2005: eszopiclone (Lunestaâ„¢ manufactured by Sepracor – US). Eszopiclone has the advantage ... EMS1.com 불면ì¦?약 '루네스타' 美 특허기간 2ë…„ 연장 - Dec 21, 2009 ...ì?¼ë³¸ 다ì?´ë‹›í?°ìŠ¤ë¯¸í† ëª¨ì œì•½ì?˜ 불면ì¦? ì¹˜ë£Œì œ '루네스타'(Lunesta, eszopiclone)ê°€ 미êµì—?ì„œ 특허기간ì?„ 연장받았다. 다ì?´ë‹›í?°ìŠ¤ë¯¸í† 모는 ë¯¸êµ ìž?회사ì?¸ 세프ë?¼ì½”ê°€ ... 디지틀보사 大日本ä½?å?‹è£½è–¬ã€?セプラコール社ã?®ä¸?çœ ç—‡æ²»ç™‚è–¬ã?®ç‰¹è¨±æœŸé–“延長をèª?ã‚?る通知å?—é ˜ - Dec 17, 2009 ...ã?“ã‚Œã?«ã‚ˆã‚Šã€?ＬＵＮＥＳＴＡ（Ｒ）ã?®ç‰¹è¨±æœŸé–“ã?¯ï¼—ï¼–ï¼?日間延長ã?•ã‚Œã€?ï¼’ï¼?１４年２月１４日ã?¾ã?§å˜ç¶šã?™ã‚‹ã?“ã?¨ã?«ã?ªã‚Šã?¾ã?™ã€‚ã?ªã?Šã€?ＦＤＡã?®ï¼·ï½’ｉｔｔｅｎ Ｒｅｑｕｅｓｔ ... 日本経済新聞 (プレスリリース) Cegah Pintas Menjemput Alam Baka - Dec 20, 2009 Dokter biasanya akan memberikan pil tidur untuk mengobati insomnia, seperti Ambien, Lunesta, Restoril, atau Sonata. Namun, dengan membangun kebiasaan tidur ... Tempo Interaktif Mandi Cahaya Matahari Cegah Jet Lag - Dec 20, 2009 Saat terbang dari Timur ke Barat, obat tidur yang lebih tahan lama, seperti Lunesta atau Ambien CR cenderung bekerja lebih baik. ... Travelista 任百鸣：è°?是“梦游凶案â€?的真æ£æ?€æ‰‹ï¼Ÿ 作者：任百鸣 - Dec 10, 2009 ...美国è?”邦食å“?暨è?¯ç‰©ç®¡ç?†å±€ï¼ˆFDA）二零零七年三月å??四日宣布，包括Ambien（美国Zolpiderm的商å“?å??）ã€?Lunesta（å¦å??是Eszopiclone）在内的å??三ç§?å®‰çœ è?¯ï¼Œå¿…须在外包装和 ... 大纪元 Thuốc ngủ thế hệ má»›i cÅ©ng không Ãt tác dụng phụ - Dec 16, 2009 Thuốc ngủ thế hệ má»›i không có cấu trúc benzodiazepine, gá»?i chung là nhóm nonbenzodiazepin bao gồm: zolpidem (ambien, ivedal), eszopiclon (lunesta), ... Báo Hoà Bình For insomniacs, a sleeping pill for every night; Lunesta is the first... - Jan 17, 2005 In mid-December, the Food and Drug Administration approved a new prescription sleep aid -- a hypnotic, in medical parlance -- called eszopiclone. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Sepracor, Glaxo Ink Deal for Lunesta - Sep 11, 2007 By Elizabeth Trotta 09/11/07 - 10:13 AM EDT. Sepracor(SEPR Quote) and GlaxoSmithKline(GSK Quote) said Tuesday that they inked an agreement to commercialize ... TheStreet.com - TheStreet.com (subscription) Sepracor Up on Lunesta Study - Dec 4, 2006 By Althea Chang 12/04/06 - 03:15 PM EST. Sepracor's (SEPR Quote) shares rose after the company reported positive results from a trial of its insomnia drug ... TheStreet.com - TheStreet.com (subscription) Lunesta Wakes Up Sepracor - Oct 26, 2006 By Althea Chang 10/26/06 - 12:04 PM EDT. Drug developer Sepracor(SEPR Quote) swung to a profit in the third quarter thanks to strong sales of its asthma ... TheStreet.com - TheStreet.com (subscription) Doctors criticize sleeping-pill ads.(Lunesta from Sepracor Inc.) - Aug 18, 2005 Aug. 18--An advertising campaign by Sepracor Inc. is drawing fire from psychiatrists who say the Marlborough company misrepresents its new sleeping pill. ... Free with registration - Boston Globe - AccessMyLibrary.com $300 Mil.+ Lunesta Biz to Kaplan Thaler - Jan 31, 2008 NEW YORK Publicis Groupe's The Kaplan Thaler Group has landed creative duties on Sepracor's Lunesta after a review involving a handful of contenders, ... Adweek FDA Issues Warning on Sleeping Pills - Mar 15, 2007 Ambien and Lunesta are among the 13 sleep medications that the FDA has ordered ... The FDA ordered the makers of Ambien, Lunesta and 11 other commonly used ... New York Times Analysts worry as Lunesta sales growth eases.(sedate sleeping pill... - Aug 20, 2005 Aug. 20--New prescriptions for Sepracor Inc.'s Lunesta sleeping pill are leveling off after a hot start this spring, causing some analysts to worry that the ... Free with registration - Boston Globe - AccessMyLibrary.com Record Sales of Sleeping Pills Are Causing Worries - Feb 7, 2006 But Dr. Carlat warned that Lunesta, because it was longer acting, was more likely to cause next-day sleepiness problems "in comparison with some of its ... New York Times Sepracor hikes price of Lunesta sleep drug-analyst - Jun 14, 2007 BOSTON, June 14 (Reuters) - Sepracor Inc. (SEPR.O) has raised the price of its insomnia drug Lunesta by 9 percent as the company moves to shore up the drug ... Reuters Sepracor's Lunesta Could Drive Stock Upside - Sep 23, 2005 Goldman Sachs initiated coverage on Sepracor (nasdaq: SEPR - news - people ) with an "outperform" rating, saying the current value of the shares do not ... Forbes Tiny rival sues Sepracor over Lunesta moth - Dec 4, 2006 By Stephen Heuser, Globe Staff | December 4, 2006. The glowing green moth that advertises the sleeping pill Lunesta has become one of the best-known logos ... Boston Globe Buzzkill For Sepracor - Jul 29, 2008 Meanwhile, sales of the company's insomnia drug, Lunesta, were up slightly to $148.1 million ... Lunesta is a competitor of Ambien and its generic forms. ... Forbes Sepracor Ailing - Jul 27, 2007 Lunesta sales increased 2.7%, to $143.0 million up from $139.1 million the previous year. ... “Lunesta revenues have been flat for seven quarters. ... Forbes Drug to shake up insomnia market. - Apr 2, 2005 The Food and Drug Administration will let Sepracor claim that Lunesta will keep ... Lunesta will treat problems that studies have shown are widespread among ... Free with registration - Boston Globe - AccessMyLibrary.com Sleep Drugs Found Only Mildly Effective, but Wildly Popular - Oct 23, 2007 Newer drugs like Lunesta and Ambien CR, a controlled-release formula, ... Users also sometimes report that Lunesta leaves a bad taste in their mouths, ... New York Times Sepracor doubles Q1 revenue, turns profit - Apr 25, 2006 Lunesta, the company's most recent drug to gain federal regulator approval, generated $138.1 million in revenue during the latest quarter, nearly matching ... Bizjournals.com No Sleep for Sepracor - Apr 25, 2005 Lunesta prescriptions are off to a good start, Marc Goodman of Morgan ... Sepracor's strategy for Lunesta is not only to challenge Ambien but also to seek ... TheStreet.com - TheStreet.com (subscription) Gradeons: Vitamin D deficiency a problem in kids | Life | Chron.com -... - Sep 11, 2008 When I take Lunesta to go to sleep, the next day my eyesight is ... I only take the Lunesta twice a week. Has anyone else reported this weird occurrence? ... Houston Chronicle Sepracor rises on bad news for rival, positive test results - Jun 24, 2006 The placebo-controlled trial, among four Lunesta clinical trials ... Other trials presented on Thursday studied Lunesta use among patients who were ... Boston Globe WHAT'S IN THE BOTTLE?, For insomniacs, Lunesta may be dream pill - Jan 25, 2005 CORRECTION: A Los Angeles Times story yesterday in Part 2 misstated the cost of a new sleeping pill, Lunesta. The drug would be about 28 percent more ... Pay-Per-View - Newsday - ProQuest Archiver Takeda dreams of waking slumbering pill's sales: A Chicago-area … - Jun 15, 2007 Ambien and Lunesta target benzodiazepine receptors that exist throughout the ... "Anybody who has taken Ambien, Lunesta, Sonata ... they feel a sedating ... Free with registration - Chicago Tribune - AccessMyLibrary.com Sepracor moves toward marketing drug in Europe - Oct 24, 2008 Sepracor noted that Lunivia is widely marketed in the United States under the brand name of Lunesta. With a glowing green moth used as a brand icon, ... Boston Globe Sepracor's Lunesta Sales Seen Losing Steam - Jan 23, 2006 Piper Jaffray maintained a "market perform" on Sepracor (nasdaq: SEPR - news - people ) ahead of the biotech firm's fourth-quarter earnings report. ... Forbes Sepracor's Lunesta an immediate success in burgeoning market for … - Jul 24, 2005 With its second-quarter financial report last week, pharmaceutical developer Sepracor Inc. disclosed that its new insomnia drug, Lunesta, brought in $83.5 ... $1.95 - Worcester Telegram Gazette - NewsBank Drug Ads Play Up Benefits, Downsize Risks : NPR - Apr 13, 2007 In the Lunesta ad, there are lots of details, including a litany of side ... Unidentified Woman: Until you know how you react to Lunesta, you should not ... NPR TVTM 81 - Putting the "lune" in Lunesta - Nov 6, 2008 In this short (at least by TVTM standards) but action-packed, post-election podcast, TV critic Tim Goodman and Manny are just ROFL as Question Boy Joe ... San Francisco Chronicle Ad War Over Sleep Aids Predicted - Jul 20, 2005 ...based manufacturer of Lunesta, has nearly tripled the size of its sales staff ... Lunesta averaged about 60000 new prescriptions per week after its launch, ... CBS News Ambien fallout hurts Lunesta - Sepracor stock also slumping - Apr 11, 2006 MARLBORO - Sales of Sepracor Inc.'s insomnia drug, Lunesta, have slid since concerns about sleep drugs and sleepwalking arose last month, but nighttime ... $1.95 - Worcester Telegram Gazette - NewsBank Sepracor shares fall as revenue disappoints Wall Street - May 2, 2008 ..."Lunesta prescriptions remain in double-digit decline even though the company has made numerous changes to address this issue." ... Boston Globe Lunesta sales rouse Sepracor shares - Oct 31, 2007 DreamWorks Animation chief executive Jeffrey Katzenberg sees green with and from Shrek, as company profits quadrupled in the third quarter to $47 million. ... Boston Globe Ad campaign may jolt sales of sleeping pill. - Jul 17, 2006 Rozerem will compete against drugs like Ambien and Lunesta, both of which list ... But Ambien, Lunesta and others target benzodiazepine receptors that exist ... Free with registration - Chicago Tribune - AccessMyLibrary.com Sepracor Up on Rival's Setback - Apr 11, 2005 The FDA approved Lunesta on Dec. 15, and the company originally predicted the drug would reach the market in January. But getting DEA approval delayed ... TheStreet.com - TheStreet.com (subscription) Sepracor to restate results due to govt billing - Jan 28, 2008 Sepracor, which sells insomnia drug Lunesta and asthma drug Xopenex, said it notified the US Centers for Medicare and Medicaid Services earlier this month ... Reuters Adrian Adams named new CEO of Sepracor - May 15, 2007 The Marlborough, Mass., maker of blockbuster insomnia treatment Lunesta ... Other than Lunesta, the company also sells bronchitis treatments Xopenex HFA and ... Bizjournals.com Sales of Lunesta boost Sepracor to first profitable year - Jan 31, 2006 Sepracor Inc. achieved its first profitable year in 2005, thanks in large part to booming sales of its insomnia drug Lunesta. ... Boston Business Journal LUNESTA(R) Next-Day Function And Discontinuation Data From A Long- … - Sep 5, 2008 Sepracor Inc. (Nasdaq: SEPR) announced the presentation of LUNESTA ® brand eszopiclone Phase IV study data at the 21st European College of ... Medical News Today - Medical News Today (press release) Article: You May Want to Sleep on It; Enter the Next 'Miracle' Drug:... - Jan 18, 2005 Ads for Lunesta Won't Likely Give That Theme a Rest. This Time Will Consumers Be More Leery? ... find The Washington Post articles. Pay-Per-View - Washington Post - HighBeam Research Medicare to cut payback on Sepracor drug-analyst - May 18, 2007 Officials at Sepracor, which also makes the insomnia drug Lunesta, were not immediately available for comment. Last year, sales of Xopenex approached $600 ... Reuters Eye On Stocks Eye On Stocks For Tuesday, April 25, 2006 - Apr 25, 2006 ..."With the slowing down of Lunesta prescriptions trajectory, the pricing threat on Xopenex from Medicare, and the potential competitive approval of Indiplon, ... Forbes Inverness loss narrows in quarter - Jul 30, 2008 Sepracor Inc., the maker of the Lunesta sleeping pill, fell the most in a year after it trimmed its 2008 forecast and missed second-quarter earnings ... Boston Globe Sepracor reports lower profit, announces layoffs - MarketWatch - Oct 30, 2007 Sales of the company's sleep aid, Lunesta, jumped 14% to $160.9 million from last year. However, sales of Xopenex HCL Inhalation Solution slid from $125.4 ... MarketWatch Sepracor Announces Third Quarter 2005 Operating Results. - Oct 25, 2005 LUNESTA is approved for long-term use. Launched in April 2005, LUNESTA 1 mg, ... During the third quarter, Phase IIIB/IV data related to LUNESTA were ... Free with registration - Business Wire - AccessMyLibrary.com Sepracor Announces Presentation of LUNESTA(TM) Posters at … - Jun 21, 2006 Sepracor Inc. (Nasdaq: SEPR) today announced that data for LUNESTA(TM) brand eszopiclone for the treatment of insomnia were presented at the SLEEP 2006 20th ... Genetic Engineering News - Genetic Engineering News (press release) LUNESTA(R) Study Of Patients With Insomnia And Co-Morbid … - May 14, 2008 Sepracor Inc. (Nasdaq: SEPR) announced the publication of a study of LUNESTA tablets in patients with insomnia and co-morbid generalized anxiety disorder ... Medical News Today - Medical News Today (press release) Sepracor Shares Drop as Forecast Dips Below Estimates - Jan 31, 2007 Sepracor plans to boost marketing for Lunesta, the most heavily advertised drug ... Lunesta, locked in a television ad war with Sanofi- Aventis SA's Ambien, ... Bloomberg New sleeping aid may open eyes - Feb 13, 2005 Lunesta breaks new ground on at least two counts. When taken at bedtime, ... At an average wholesale price of $3.70 per tablet, Lunesta will not be a cheap ... Seattle Times Generic Smear Campaign - May 9, 2006 ...(Ambien and Lunesta can cost $3 a pill or more.) And in the only sizable study to compare trazodone with Ambien as a sleep aid, the two drugs performed ... New York Times Focus on Lunesta after incident - Oct 25, 2008 The sleeping pill that reportedly led to an overdose at Isiah Thomas' house Friday is unique because it can be prescribed for a significantly longer period ... Pay-Per-View - Newsday - ProQuest Archiver Eisai, Sepracor Announce Partnership for Lunesta in Japan - Jul 27, 2007 Sepracor announced an agreement with Eisai for the development and commercialization of Lunesta, Sepracor's insomnia drug, for the Japanese market. ... FDA news - FDA news (subscription) Sleeping pill choices a tossup - Dec 20, 2005 The Oregon Evidence-based Practice Center, which compares the efficacy and safety of different drugs, looked at 141 studies of Sonata, Ambien, Lunesta and ... Rocky Mountain News Atlanta health, diet and fitness news | ajc.com - Jan 15, 2006 In the ads for the new sleep drug Lunesta, a pale green luna moth — they're nocturnal ... Sales of Lunesta, launched in early 2005, have been brisk. ... Atlanta Journal Constitution Pharmacy prices tracked on Web - Feb 13, 2008 A search of drug prices in the Buffalo region, for example, found that a 30-dose prescription of the sleep aid Lunesta was $132.66 at the lowest reported ... Bizjournals.com LUNESTA(TM) Perimenopause-Menopause Study Data to Be Presented … - Sep 30, 2005 Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from its Phase IIIB/IV study evaluating safety and efficacy of LUNESTA(TM) brand ... RedOrbit Lunesta in Play; McCann Defends - Dec 14, 2007 NEW YORK Sepracor is reviewing US creative duties on its Lunesta sleep aid and incumbent McCann HumanCare is believed to be defending, sources said. ... Adweek Neurocrine Investors Advised To Take Profits - May 15, 2006 In addition, slowing sales for rival drugs Lunesta and Ambien CR, along with the debut ... Lunesta is made by Sepracor (nasdaq: SEPR - news - people ) while ... Forbes Sepracor scaling back its sleep-aid advertising - The Boston Globe - Oct 6, 2008 ..."I think they are questioning the value of their ad spending" on Lunesta, ... In 2006 and 2007, Lunesta was widely ranked as the most heavily advertised ... Boston Globe LUNESTA(TM) Second Six-Month Study Data Confirms Findings of First … - Apr 11, 2005 MARLBOROUGH, Mass., April 11 /PRNewswire-FirstCall/ -- Sepracor Inc. today announced preliminary results from its second six-month, Phase IIIB/IV, ... RedOrbit Revenue Jumps at Sepracor | Biotech/Pharmaceuticals | Financial … - Jul 19, 2005 However, the strong showing -- bolstered by its insomnia drug Lunesta ... Lunesta, which was launched in April, recorded sales of $83.5 million for the ... TheStreet.com - TheStreet.com (subscription) For some, Lunesta leaves bad taste with good night's sleep - Jul 15, 2006 Q. I recently tried Lunesta. It helped me get a good night's sleep, but for the next two days I had a horrible metallic taste in my mouth. ... Youngstown Vindicator Report: Go Easy on Sleeping Pills - Aug 15, 2006 Other heavily marketed sleeping pills include Lunesta, Rozerem, Sonata and Ambien CR. Average cost for 15 doses of these drugs ranges from $51 for Rozerem ... Washington Post Study: Insomnia Can Trigger Depression - Jun 27, 2005 He recommends trying one of the new generation of prescription hypnotic sleep drugs, such as Ambien, Sonata, or Lunesta, or trying behavioral therapy that ... FOXNews Valley of the Dollars - Feb 20, 2006 Lunesta, on the other hand, has no recommended time limit. So far, Lunesta has claimed around 10% of the market. (Yet in a survey done by one Wall Street ... CNNMoney.com LUNESTA(TM) Data Presented at American College of Rheumatology … - Nov 15, 2005 Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of results from its Phase IIIB/IV, 153-patient, four-week, randomized, double-blind, ... RedOrbit Sepracor would bring risks, as well as rewards, to acquirer - Jun.... - Jun 20, 2006 Sepracor's sleeping pill Lunesta could look especially attractive to Pfizer, ... Sepracor's other product, the sleeping pill Lunesta, totaled $329 million ... CNNMoney.com USA TODAY Education - Career and Technical Education - Feb 27, 2006 Ads for prescription sleeping pills such as Ambien and Lunesta have indeed become a familiar presence, particularly in media aimed at women, ... USA Today Sepracor to Sell European Rights to Lunesta - Nov 10, 2006 Sepracor Inc. plans to sell European rights to its Lunesta sleeping aid and will include data on the drug's benefits on depression in the application for ... Bizjournals.com Biotech Stocks Hold Steady - Jun 26, 2006 ..."With the threat of competing against a Pfizer launch eliminated we believe that Lunesta will achieve greater market penetration in 2007 and beyond," it ... Forbes THE HEALTHY TRAVELER; New weapons in travelers' round-the-clock … - Apr 23, 2006 Three new sleeping pills, Ambien, Lunesta and Sonata, have fewer and less-severe adverse effects, ... "Lunesta (eszopiclone) provides seven or eight hours. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Drugmakers Are Changing Channels - Aug 15, 2005 When drugmaker Sepracor Inc. (SEPR )launched its insomnia drug, Lunesta, ... Despite the lavish spending for Lunesta, the overall market for prescription ... BusinessWeek Sepracor Announces Presentation of LUNESTA(TM) Data at American … - May 25, 2006 MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that data from its Phase IIIB/IV studies of LUNESTA(TM) brand eszopiclone for the ... Free with registration - Business Wire - AccessMyLibrary.com Sepracor's (SEPR) Shares Now Cut In Half - Jul 27, 2007 According to Reuters: Revenue from Lunesta, the company's popular insomnia drug, grew just slightly, to $143.0 million from $139.1 million a year ago as ... MarketWatch Insomnia: Talk Therapy Beats Sleeping Pills - Jun 27, 2006 Imovane, a sleep drug closely related to Lunesta, is commonly used in Europe but is not available in the US. After six weeks of treatment -- and again six ... FOXNews Sepracor Posts Loss on License Payment, Cuts Forecast - Feb 29, 2008 29 (Bloomberg) -- Sepracor Inc., the maker of Lunesta sleeping pills, ... Sales of the sleep drug Lunesta rose 1.5 percent to $149.8 million. ... Bloomberg The Boston Globe Boston Capital column. - Feb 22, 2005 Sepracor Inc. of Marlborough is poised for the megalaunch of its Lunesta sleeping pill, ... A drug like Lunesta would easily be the most-anticipated new ... Free with registration - Boston Globe - AccessMyLibrary.com Business | projo.com | The Providence Journal - Feb 18, 2005 ...based developer of the Lunesta sleeping pill approved by the US Food and Drug ... 16, the day after the FDA approved Lunesta. The stock more than doubled ... Providence Journal It's a wake-up call for insomniacs // 1st sleeping pill OKd for long... - Jan 10, 2005 More than 1200 sales representatives are promoting Lunesta to doctors, and next month, ... The Lunesta rollout is the drug industry's latest attempt to get ... $2.95 - Chicago Sun-Times - NewsBank Critics Worry About Sleeping Pills' 'Unknown Risk' - Mar 5, 2006 Ambien, Lunesta, and Sonata are part of a new class of drugs some call breakthroughs. They are supposed to have few or no side effects, so many doctors are ... ABC News Sleeping Pills: The Next Generation - Aug 1, 2005 In April, Sepracor launched Lunesta, the first sleep drug approved with no time limit for use. (Drugs like Ambien are recommended for 10 days or less ... Pay-Per-View - Newsweek - Factiva, from Dow Jones Sepracor Gets Brovana Boost - Oct 9, 2006 ...based company, best known for the insomnia drug Lunesta, said late Friday that the Food and Drug Administration approved Brovana as maintenance therapy for ... TheStreet.com - TheStreet.com (subscription) Sepracor to Restate Results - Aug 10, 2006 The Marlborough, Mass., drugmaker, best known for the insomnia drug Lunesta, also said it won't be able to file a timely second-quarter financial report ... TheStreet.com - TheStreet.com (subscription) Results of Sepracor's LUNESTA(R) Next-Day Driving Study in Patients … - Dec 6, 2006 Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA(R) brand eszopiclone that measured the effects on actual ... Genetic Engineering News - Genetic Engineering News (press release) Sepracor's executive chairman to retire by May 13 - Dec 31, 2007 O), maker of the insomnia drug Lunesta, said on Monday that Timothy Barberich, its executive chairman and former chief executive, will retire by May 13, ... Reuters What's Holding Up the Sandman? - Apr 11, 2006 You could hardly have missed that pale green luna moth (sans antennas) drifting over peaceful sleepers in ads for Lunesta, which has joined Ambien, ... New York Times LUNESTA Phase III/IV Data Presented at 2005 Associated Professional … - Jun 22, 2005 Sepracor Inc. (Nasdaq: SEPR) announces that it will be presenting LUNESTA(TM) brand eszopiclone posters today at the 19th Annual Meeting of the Associated ... RedOrbit THE NATION; Wake Up: You May Not Need a Pill to Sleep - Aug 8, 2006 Other sleeping pills were within similar price ranges: $25 for King Pharmaceuticals Inc.'s Sonata and $30 for Sepracor Inc.'s Lunesta. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Sepracor Names New COO - Mar 2, 2007 Sepracor makes the insomnia drug Lunesta and asthma drug Xopenex. The announcement came after the market closed Thursday. O'Shea, 57, had been president and ... TheStreet.com - TheStreet.com (subscription) Sepracor profit doubles but revenue disappoints - Apr 24, 2007 Sales of its sleep drug Lunesta rose 7.4 percent to $148.3 million. The class-action suits, which were pending in US Court for the District of Massachusetts ... Reuters Sleeping Pill Wars - Feb 18, 2006 The best seller is currently Ambien, but over the past year it has been vigorously challenged by a newcomer, Lunesta, prompting a huge advertising and ... New York Times Boston Scientific shares rise 6.4 after verdict - Jul 6, 2005 Sepracor Inc.'s Lunesta sleeping pill, which four US regulators initially wanted to reject last year on cancer concerns, has no advantage over generic ... Boston Globe Wall Street Journal: Lunesta off to strong start - May 13, 2005 Sepracor's Lunesta is exceeding early projections, selling briskly and eroding Ambien's market share in the sleeping pill category, according to an article ... Medical Marketing & Media - Medical Marketing and Media Sepracor boosts Lunesta price - Jun 15, 2007 Sepracor Inc. has raised the price of its blockbuster insomnia drug Lunesta by 9 percent even as prescription growth in the overall market begins to ... Bizjournals.com … Publication of Additional Data From Lunesta(R) Insomnia-Depression... - Feb 21, 2007 Sepracor Inc. (Nasdaq: SEPR) today announced that additional data from its Phase IIIB/IV, 545-patient study of LUNESTA® brand eszopiclone in patients with ... RedOrbit Pharma ads should have us all losing sleep - Apr 30, 2006 The manufacturers of Ambien and Lunesta earned the While You Were Sleeping award for ... Meanwhile, Lunesta is still running so-called reminder ads, ... Pay-Per-View - Chicago Tribune - ProQuest Archiver The Memorable Lunesta Moth Wins Again - Oct 23, 2007 By Ed Silverman // October 23rd, 2007 // 5:34 pm. If nothing else, the ad campaign for Sepracor's sleeping pill is getting attention. ... Pharmalot Sepracor Announces Publication of LUNESTA(TM) Insomnia-Depression … - Apr 4, 2006 Sepracor Inc. (Nasdaq: SEPR) today announced that data from its Phase IIIB/IV, 545-patient study of LUNESTA(TM) brand eszopiclone in patients with insomnia ... RedOrbit Lunesta Sleep Aid Available in 24 Hours to Any Pharmacy, Company … - Apr 11, 2005 By Tucker Sutherland, editor. April 11, 2005 - Lunesta is listed in the national pharmacy order management system, and is available to pharmacies within 24 ... SeniorJournal.com Lunesta Wins Most-Remembered-Ad Slot - Jun 5, 2007 The most-often-recalled prescription drug ad aired during the last television season was for sleep aid Lunesta, according to data released by IAG Research. ... Media Buyer Planner Lunesta Data Presented at 2005 American Psychiatric Association … - May 29, 2005 Sepracor Inc (Nasdaq: SEPR) today announced that it has presented four LUNESTATM brand eszopiclone posters at the 158th annual meeting of the American ... i-newswire.com What drugs Heath Ledger took | The Daily Telegraph - Jan 25, 2008 Lunesta is used to treat insomnia. This medication causes relaxation to help you ... Lunesta may also be used for purposes other than those listed in this ... NEWS.com.au |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
